From Volume to Value: How RCM Strategies Are Evolving for Value-Based Care

Revenue cycle management was designed for fee-for-service. Submit a claim. Get paid. Deny the denial. Repeat. The optimization target is simple: maximize the number of clean claims that reach payers and minimize the time it takes to collect on them.

Value-based care breaks that model. Under ACO arrangements, Medicare Advantage quality contracts, Medicaid managed care value-based arrangements, and commercial bundled payment programs, the revenue cycle no longer optimizes for claim volume. It optimizes for quality performance, cost outcomes, care gap closure rates, and patient engagement metrics — measures that determine whether a shared savings payment is received or a penalty is assessed.

This shift demands a fundamentally different revenue cycle strategy. This article covers what changes, what stays the same, and what the operational components of effective value-based care RCM look like in 2026.

What Value-Based Care Changes About Revenue Cycle Management

The transition from fee-for-service to value-based care doesn’t eliminate traditional RCM. Clean claims still need to be submitted. Denials still need to be appealed. Patient balances still need to be collected. But these functions become table stakes rather than the primary performance lever.

The new performance levers are upstream — and they require RCM to reach further into clinical operations than it ever has under fee-for-service.

RCM Function	Under Fee-for-Service	Under Value-Based Care
Primary revenue driver	Volume of services billed and collected	Quality measure performance; total cost vs. benchmark
What RCM tracks	Claims, AR days, denial rate, clean claim rate	HEDIS measures, ED utilization, readmission rate, care gap rates, risk scores
Patient engagement role	Billing statement and collections function	Preventive care outreach, medication adherence, and care gap closure directly affect revenue
Risk adjustment	Coding completeness for billing accuracy	HCC capture determines the capitation rate and benchmark — a direct revenue variable
Cost management	Minimizing cost to collect; not involved in care cost	Directly responsible for utilization management and total cost tracking

Quality Measures Are Now a Revenue Cycle Function

Under Medicare Advantage, HEDIS quality measures determine Star ratings. Stars’ ratings determine quality bonus payments. Quality bonus payments represent hundreds of dollars per member per year for 4-star and 5-star plans.

Under MSSP ACO arrangements, quality performance determines whether an organization earns shared savings or owes shared losses. Under commercial value-based contracts, quality bonuses and penalties are calculated against defined measure thresholds.

In every case, quality measures drive revenue. And quality measures are driven by care gap closure, which is driven by patient engagement and outreach. This makes patient outreach a revenue-cycle function in value-based care.

Consider the math for a Medicare Advantage plan moving from 3.5 to 4 stars. The quality bonus revenue for a 4-star plan is substantially higher than for a 3.5-star plan — across every enrolled member, for the full plan year. The outreach program that closes HEDIS care gaps and moves CAHPS scores is generating that revenue as directly as any claims submission workflow.

This is why effective value-based care RCM teams include — or closely partner with — the proactive patient outreach functions that drive quality measure performance. These aren’t separate departments under value-based care. They are the same function viewed from different angles.

Risk Adjustment Under Value-Based Care — More Than a Coding Exercise

Under Medicare Advantage and many ACO models, risk adjustment determines payment. Plans and ACOs receive per-member capitation payments calibrated to the health risk of their patient population — based on Hierarchical Condition Category (HCC) risk scores. More accurately documented chronic conditions generate higher risk scores. Higher risk scores generate higher capitation. Better capitation funds, better care.

Risk adjustment documentation in value-based care is not a game. It is a clinical accuracy imperative. Patients whose conditions are correctly and completely documented receive the capitation that funds their care. Patients whose conditions are underdocumented receive less funding, which results in less care.

Value-based care RCM teams track HCC capture rates and gap analysis as primary performance metrics. They identify patients whose documented risk scores don’t reflect their actual clinical complexity. They drive AWV completion to create the documentation opportunity. And they train clinical documentation improvement specialists to capture all relevant conditions accurately at every encounter.

Utilization Management — Where Cost and Quality Intersect

Under fee-for-service, utilization management is a payer function — plans use it to control what they pay providers. Under value-based care, it becomes a provider and ACO function. Organizations that bear financial risk for the total cost of care need to actively manage that cost.

Effective value-based RCM includes utilization management programs that reduce avoidable costs. The most impactful are:

ED diversion through nurse triage.

Emergency department visits are among the most expensive utilization events. A structured nurse triage service intercepts avoidable ED visits by providing after-hours clinical guidance that redirects members to appropriate lower-acuity care. For ACOs and MA plans that bear total cost risk, ED diversion programs generate a direct financial return.

Post-discharge transition support.

Hospital readmissions within 30 days are among the most preventable high-cost events. Structured post-discharge outreach — confirming medication understanding, verifying follow-up appointments, identifying early warning symptoms — reduces readmissions. Under value-based models, every avoided readmission represents retained revenue.

Medication adherence programs.

Non-adherent patients with diabetes, hypertension, and heart failure generate higher downstream costs through complications, emergency visits, and hospitalizations. Adherence outreach programs that keep patients on their medications reduce the total cost of care, which improves performance against the benchmark in shared savings arrangements.

Utilization Program	Cost Mechanism	Value-Based Revenue Impact
ED diversion	Avoids $800–$1,500 average ED claim	Reduces total cost vs. benchmark; improves shared savings performance
Readmission prevention	Avoids $8,000–$15,000 inpatient readmission cost	Reduces total cost; improves HRRP penalty position for hospitals
Medication adherence	Prevents downstream complication costs	Improves HEDIS adherence Stars measures; reduces acute care utilization
AWV completion	Enables early intervention before acute events	Improves HCC capture; generates Stars measure credit; reduces downstream cost

The Data Infrastructure Value-Based Care RCM Requires

Traditional RCM runs on claims data. Value-based care RCM runs on claims data plus clinical data, quality measure performance data, utilization analytics, and population health metrics. These data streams don’t naturally connect. Building the infrastructure to connect them is one of the most significant operational challenges in transitioning to value-based RCM.

The specific data capabilities value-based RCM requires:

Real-time quality measure dashboards. RCM teams need current HEDIS measure performance — by measure, by provider, by patient population segment — with enough lead time to deploy outreach before measurement windows close. A dashboard that shows Q4 HEDIS performance in January is too late to act on.

Attributed population visibility. Under ACO and MA models, the organization is financially responsible for a defined attributed patient population. RCM teams need to see which patients are attributed, what their care gaps are, and which are at risk of generating high-cost utilization events — proactively, not retrospectively.

Cost vs. benchmark tracking. Under shared savings arrangements, the organization earns savings only if actual cost comes in below the benchmark. RCM teams need real-time visibility into total cost trajectory against benchmark — not just annual reconciliation.

HCC gap analysis. Which patients have documented chronic conditions that aren’t reflected in current risk scores? HCC gap analysis identifies the documentation opportunities that, when captured at the next encounter, improve capitation and fund better care.

What Doesn’t Change — Traditional RCM Still Matters

Value-based care doesn’t eliminate traditional revenue cycle management. Most organizations operate a hybrid model — some revenue from fee-for-service, some from value-based arrangements. Even fully capitated organizations still generate fee-for-service claims for services outside their capitation scope.

Clean claim rates, denial management, eligibility verification, and AR management remain essential. The organizations that struggle most under value-based care are those that either ignored traditional RCM quality in favor of value-based programs — or ignored value-based RCM capabilities in favor of traditional claims management.

The goal is both. Clean claims management funds current operations. Value-based RCM performance determines whether shared savings, quality bonuses, and improved capitation fund future growth.

The 2026 healthcare RCM trends guide covers the full range of forces reshaping revenue cycle — including prior authorization reform, AI-assisted denial management, and the No Surprises Act — that affect organizations across both fee-for-service and value-based models.

What to Outsource in Value-Based Care RCM

Value-based care RCM requires capabilities that most in-house revenue cycle teams lack. Patient outreach infrastructure. Care gap closure programs. Post-discharge follow-up capacity. Nurse triage operations. Multilingual engagement for LEP populations.

Organizations that try to build all of these capabilities in-house simultaneously face a long implementation timeline and high fixed costs. The more practical approach — and the one most health systems are adopting in 2026 — is a hybrid model that outsources high-volume, well-defined programs to specialized partners while retaining strategic oversight, population health analytics, and payer relationship management in-house.

VBC RCM Function	In-House or Outsource	Rationale
Population health analytics and strategy	In-house	Requires deep knowledge of attributed population and payer contracts
HEDIS care gap closure outreach	Outsource	High volume, well-defined, specialized partners have outreach scale
HCC documentation strategy	In-house with specialist support	Requires clinical knowledge; CDI expertise often outsourced
AWV scheduling outreach	Outsource	High volume; specialized partner has scheduling integration
Post-discharge follow-up	Outsource	24/7 coverage requirement; volume too high for in-house at scale
Payer contract performance management	In-house	Requires institutional relationship and negotiation continuity

The Value-Based Care RCM Scorecard

Value-based care RCM teams need a different performance scorecard than traditional RCM. The metrics that matter are a blend of traditional revenue cycle measures and value-based performance indicators:

Metric Category	Specific Metrics	Revenue Connection
Traditional RCM	Clean claim rate, AR days, denial rate, collection rate	FFS revenue optimization
Quality performance	HEDIS measure rates, Stars rating, CAHPS scores	Quality bonuses; Stars bonus payments
Risk documentation	HCC capture rate, AWV completion, RAF score vs. benchmark	Capitation rate; shared savings benchmark
Utilization performance	30-day readmission rate, ED utilization per 1,000, total cost vs. benchmark	Shared savings performance; penalty avoidance
Patient engagement	Care gap closure rate, outreach contact rate, adherence PDC	Quality measure performance; cost reduction

Organizations that track this full scorecard — and connect each metric to its revenue implication — make better investment decisions about where to focus RCM improvement efforts. The organization that knows its HCC capture rate is 12 points below the benchmark knows exactly where its capitation revenue is leaking.

For the full 2026 RCM landscape — including how prior authorization reform, AI denial management, and price transparency requirements intersect with value-based models — the healthcare RCM trends 2026 guide covers all eight forces shaping revenue cycle performance this year.